共 50 条
[41]
Real-world treatment of patients with palbociclib for HR+/HER2-advanced/metastatic breast cancer: the Europe IRIS study
[J].
Mycock, Katie
;
Zhan, Lin
;
Hart, Kieran
;
Taylor-Stokes, Gavin
;
Milligan, Gary
;
Atkinson, Christian
;
Mitra, Debanjali
.
FUTURE ONCOLOGY,
2021, 18 (03)
:349-362

Mycock, Katie
论文数: 0 引用数: 0
h-index: 0
机构:
Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England

Zhan, Lin
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, 235 East 42nd St, New York, NY 10017 USA Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England

Hart, Kieran
论文数: 0 引用数: 0
h-index: 0
机构:
Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England

Taylor-Stokes, Gavin
论文数: 0 引用数: 0
h-index: 0
机构:
Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England

Milligan, Gary
论文数: 0 引用数: 0
h-index: 0
机构:
Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England

Atkinson, Christian
论文数: 0 引用数: 0
h-index: 0
机构:
Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England

Mitra, Debanjali
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, 235 East 42nd St, New York, NY 10017 USA Adelphi Real World, Grimshaw Lane, Macclesfield SK10 5JB, Cheshire, England
[42]
Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2-Advanced Breast Cancer
[J].
Zhou, Zhou
;
Tang, Derek H.
;
Xie, Jipan
;
Ayyagari, Rajeev
;
Wu, Eric
;
Niravath, Polly A.
.
ADVANCES IN THERAPY,
2017, 34 (12)
:2566-2584

Zhou, Zhou
论文数: 0 引用数: 0
h-index: 0
机构:
Anal Grp Inc, Boston, MA 02199 USA Anal Grp Inc, Boston, MA 02199 USA

Tang, Derek H.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, E Hanover, NJ USA Anal Grp Inc, Boston, MA 02199 USA

Xie, Jipan
论文数: 0 引用数: 0
h-index: 0
机构:
Anal Grp Inc, Boston, MA 02199 USA Anal Grp Inc, Boston, MA 02199 USA

Ayyagari, Rajeev
论文数: 0 引用数: 0
h-index: 0
机构:
Anal Grp Inc, Boston, MA 02199 USA Anal Grp Inc, Boston, MA 02199 USA

Wu, Eric
论文数: 0 引用数: 0
h-index: 0
机构:
Anal Grp Inc, Boston, MA 02199 USA Anal Grp Inc, Boston, MA 02199 USA

Niravath, Polly A.
论文数: 0 引用数: 0
h-index: 0
机构:
Methodist Hosp, 6535 Fannin, Houston, TX 77030 USA Anal Grp Inc, Boston, MA 02199 USA
[43]
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant
[J].
P. Neven
;
P. A. Fasching
;
S. Chia
;
G. Jerusalem
;
M. De Laurentiis
;
S.-A. Im
;
K. Petrakova
;
G. V. Bianchi
;
M. Martín
;
A. Nusch
;
G. S. Sonke
;
L. De la Cruz-Merino
;
J. T. Beck
;
J. P. Zarate
;
Y. Wang
;
A. Chakravartty
;
C. Wang
;
D. J. Slamon
.
Breast Cancer Research,
25

P. Neven
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

P. A. Fasching
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

S. Chia
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

G. Jerusalem
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

M. De Laurentiis
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

S.-A. Im
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

K. Petrakova
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

G. V. Bianchi
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

M. Martín
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

A. Nusch
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

G. S. Sonke
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

L. De la Cruz-Merino
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

J. T. Beck
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

J. P. Zarate
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

Y. Wang
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

A. Chakravartty
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

C. Wang
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre

D. J. Slamon
论文数: 0 引用数: 0
h-index: 0
机构: Universitair Ziekenhuis Leuven,Multidisciplinary Breast Centre
[44]
Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2-advanced/metastatic breast cancer: updated systematic review
[J].
Harbeck, Nadia
;
Brufsky, Adam
;
Rose, Chloe Grace
;
Korytowsky, Beata
;
Chen, Connie
;
Tantakoun, Krista
;
Jazexhi, Endri
;
Nguyen, Do Hoang Vien
;
Bartlett, Meaghan
;
Samjoo, Imtiaz A.
;
Pluard, Timothy
.
FRONTIERS IN ONCOLOGY,
2025, 15

Harbeck, Nadia
论文数: 0 引用数: 0
h-index: 0
机构:
LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany
LMU Univ Hosp, Comprehens Canc Ctr Munich, Munich, Germany LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

论文数: 引用数:
h-index:
机构:

Rose, Chloe Grace
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, New York, NY USA LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Korytowsky, Beata
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, New York, NY USA LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Chen, Connie
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, New York, NY USA LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Tantakoun, Krista
论文数: 0 引用数: 0
h-index: 0
机构:
EVERSANATM, Value & Evidence, Burlington, ON, Canada LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Jazexhi, Endri
论文数: 0 引用数: 0
h-index: 0
机构:
EVERSANATM, Value & Evidence, Burlington, ON, Canada LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Nguyen, Do Hoang Vien
论文数: 0 引用数: 0
h-index: 0
机构:
EVERSANATM, Value & Evidence, Burlington, ON, Canada LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Bartlett, Meaghan
论文数: 0 引用数: 0
h-index: 0
机构:
EVERSANATM, Value & Evidence, Burlington, ON, Canada LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Samjoo, Imtiaz A.
论文数: 0 引用数: 0
h-index: 0
机构:
EVERSANATM, Value & Evidence, Burlington, ON, Canada LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

Pluard, Timothy
论文数: 0 引用数: 0
h-index: 0
机构:
St Lukes Canc Inst, Hematol & Med Oncol, Kansas City, MO USA LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany
[45]
Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/ HER2- metastatic breast cancer?
[J].
Forsythe, Anna
;
Chandiwana, David
;
Barth, Janina
;
Thabane, Marroon
;
Baeck, Johan
;
Shor, Anastasiya
;
Tremblay, Gabriel
.
CANCER MANAGEMENT AND RESEARCH,
2018, 10
:1015-1025

Forsythe, Anna
论文数: 0 引用数: 0
h-index: 0
机构:
Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA

Chandiwana, David
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, Global Value & Access, E Hanover, NJ USA Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA

Barth, Janina
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma GmbH, German Market Access, Nurnberg, Germany Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA

Thabane, Marroon
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut Inc, Hlth Policy & Patient Access, Dorval, PQ, Canada Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA

Baeck, Johan
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, Global Med Affairs Oncol Business Unit, E Hanover, NJ USA Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA

Shor, Anastasiya
论文数: 0 引用数: 0
h-index: 0
机构:
Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA

Tremblay, Gabriel
论文数: 0 引用数: 0
h-index: 0
机构:
Purple Squirrel Econ, Hlth Econ, New York, NY USA Purple Squirrel Econ, Hlth Technol Assessment Evidence, New York, NY USA
[46]
Cost-effectiveness analysis of elacestrant versus standard endocrine therapy for second-/third-line treatment of patients with HR+/HER2-advanced or metastatic breast cancer: a US payer perspective
[J].
Zeng, Wanxian
;
Cao, Xueqiong
;
Lin, Jingwen
;
Zheng, Bin
;
Li, Na
;
Liu, Maobai
;
Cai, Hongfu
.
FRONTIERS IN ONCOLOGY,
2023, 13

Zeng, Wanxian
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
Fujian Med Univ, Sch Pharm, Fuzhou, Fujian, Peoples R China Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China

Cao, Xueqiong
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
Fujian Med Univ, Sch Pharm, Fuzhou, Fujian, Peoples R China Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China

Lin, Jingwen
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
Fujian Med Univ, Sch Pharm, Fuzhou, Fujian, Peoples R China Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China

Zheng, Bin
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
Fujian Med Univ, Sch Pharm, Fuzhou, Fujian, Peoples R China Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China

Li, Na
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
Fujian Med Univ, Sch Pharm, Fuzhou, Fujian, Peoples R China Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China

Liu, Maobai
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
Fujian Med Univ, Sch Pharm, Fuzhou, Fujian, Peoples R China Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China

Cai, Hongfu
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
Fujian Med Univ, Sch Pharm, Fuzhou, Fujian, Peoples R China Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Fujian, Peoples R China
[47]
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN
[J].
Martinez-Janez, N.
;
Ezquerra, M. Bellet
;
Sanchez, L. M. Manso
;
Carrasco, F. Henao
;
Torres, A. Anton
;
Morales, S.
;
Ortega, P. Tolosa
;
Gil, V. L. Obadia
;
Sampedro, T.
;
Conejero, R. Andres
;
Calvo-Martinez, L.
;
Galve-Calvo, E.
;
Lopez, R.
;
de la Pena, F. Ayala
;
Lopez-Tarruella, S.
;
de Araguiz, B. A. Hernando Fernandez
;
Ruiz, L. Boronat
;
Cardenas, T. Martos
;
Chacon, J. I.
;
Anton, F. Moreno
.
BREAST CANCER RESEARCH AND TREATMENT,
2024, 206 (01)
:57-65

Martinez-Janez, N.
论文数: 0 引用数: 0
h-index: 0
机构:
Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Ezquerra, M. Bellet
论文数: 0 引用数: 0
h-index: 0
机构:
Vall dHebron Inst Oncol, Oncol Dept, Cellex Ctr, Barcelona, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Sanchez, L. M. Manso
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Carrasco, F. Henao
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Virgen Macarena, Oncol, Seville, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Torres, A. Anton
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Morales, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Arnau Vilanova Lleida, Med Oncol Dept, Lleida, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Ortega, P. Tolosa
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Gil, V. L. Obadia
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Duran i Reynals LHosp, Breast Canc Unit, ICO, Inst Catala Oncol lHosp, Lhospitalet De Llobregat, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Sampedro, T.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Cabuenes, Med Oncol Dept, Gijon, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Conejero, R. Andres
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Calvo-Martinez, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ A Coruna, Med Oncol Dept, Complexo Hosp, La Coruna, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Galve-Calvo, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Basurto, Dept Med Oncol, Bilbao, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Lopez, R.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Clin Univ, Serv Oncol Med & Grp Oncol Med Traslac, Santiago De Compostela, Spain
Inst Invest Sanitaria, CIBERONC, Santiago De Compostela, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

de la Pena, F. Ayala
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Gen Univ Morales Meseguer, Med Oncol Dept, Murcia, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Lopez-Tarruella, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Med Oncol Serv,CiberOnc,GEICAM, Madrid, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

de Araguiz, B. A. Hernando Fernandez
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Gen Yague, Med Oncol Dept, Complejo Hosp Burgos, Burgos, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Ruiz, L. Boronat
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Santa Creu i Sant Pau, Oncol Dept, Barcelona, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Cardenas, T. Martos
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Mar Parc Salut Mar, Med Oncol Dept, Barcelona, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Chacon, J. I.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Virgen Salud, Med Oncol Dept, Toledo, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain

Anton, F. Moreno
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Clin Univ San Carlos, Med Oncol Dept, Madrid, Spain Ramon & Cajal Univ Hosp, Hosp Ramon & Cajal, Med Oncol Dept, Ctra Colmenar Viejo km 9, Madrid 28034, Spain
[48]
Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor- and HER2-Positive Metastatic Breast Cancer
[J].
Delea, Thomas E.
;
Hawkes, Carol
;
Amonkar, Mayur M.
;
Lykopoulos, Konstantinos
;
Johnston, Stephen R. D.
.
BREAST CARE,
2013, 8 (06)
:429-437

Delea, Thomas E.
论文数: 0 引用数: 0
h-index: 0
机构:
Policy Anal Inc, Brookline, MA 02445 USA Policy Anal Inc, Brookline, MA 02445 USA

Hawkes, Carol
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Uxbridge, Middx, England Policy Anal Inc, Brookline, MA 02445 USA

Amonkar, Mayur M.
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Collegeville, PA USA Policy Anal Inc, Brookline, MA 02445 USA

Lykopoulos, Konstantinos
论文数: 0 引用数: 0
h-index: 0
机构: Policy Anal Inc, Brookline, MA 02445 USA

Johnston, Stephen R. D.
论文数: 0 引用数: 0
h-index: 0
机构:
Royal Marsden NHS Fdn Trust, London, England
Inst Canc Res, London SW3 6JB, England Policy Anal Inc, Brookline, MA 02445 USA
[49]
Overall survival in Japanese patients with ER+/HER2-advanced breast cancer treated with first-line palbociclib plus letrozole
[J].
Takahashi, Masato
;
Osako, Tomofumi
;
Yasojima, Hiroyuki
;
Inoue, Kenichi
;
Kawashima, Masahiro
;
Maeda, Hideki
;
Ichikawa, Akemi
;
Muramatsu, Yasuaki
;
Masuda, Norikazu
.
BREAST CANCER,
2024, 31 (01)
:53-62

论文数: 引用数:
h-index:
机构:

Osako, Tomofumi
论文数: 0 引用数: 0
h-index: 0
机构:
Kumamoto Shinto Gen Hosp, Breast Ctr, Kumamoto, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan

Yasojima, Hiroyuki
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Hosp Org Osaka Natl Hosp, Dept Surg, Breast Oncol, Osaka, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan

Inoue, Kenichi
论文数: 0 引用数: 0
h-index: 0
机构:
Saitama Canc Ctr, Div Breast Oncol, Saitama, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan

Kawashima, Masahiro
论文数: 0 引用数: 0
h-index: 0
机构:
Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan

Maeda, Hideki
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Hosp Org Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan

Ichikawa, Akemi
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Japan Inc, Med Affairs, Tokyo, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan

Muramatsu, Yasuaki
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Japan Inc, Med Affairs, Tokyo, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan

Masuda, Norikazu
论文数: 0 引用数: 0
h-index: 0
机构:
Nagoya Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Nagoya, Japan Hokkaido Univ Hosp, Breast Surg, Sapporo, Japan
[50]
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2-Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study
[J].
De Laurentiis, Michelino
;
Caputo, Roberta
;
Mazza, Manuelita
;
Mansutti, Mauro
;
Masetti, Riccardo
;
Ballatore, Zelmira
;
Torrisi, Rosalba
;
Michelotti, Andrea
;
Zambelli, Alberto
;
Ferro, Antonella
;
Generali, Daniele
;
Vici, Patrizia
;
Coltelli, Luigi
;
Fabi, Alessandra
;
Marchetti, Paolo
;
Ballestrero, Alberto
;
Spazzapan, Simon
;
Frassoldati, Antonio
;
Sarobba, Maria Giuseppina
;
Grasso, Donatella
;
Zamagni, Claudio
.
TARGETED ONCOLOGY,
2022, 17 (06)
:615-625

De Laurentiis, Michelino
论文数: 0 引用数: 0
h-index: 0
机构:
IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Caputo, Roberta
论文数: 0 引用数: 0
h-index: 0
机构:
Ist Nazl Tumori Fdn Pascale, Naples, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Mazza, Manuelita
论文数: 0 引用数: 0
h-index: 0
机构:
Ist Europeo Oncol, Senol Med, Milan, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Mansutti, Mauro
论文数: 0 引用数: 0
h-index: 0
机构:
Santa Maria Misericordia Hosp, Dept Oncol, Udine, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Masetti, Riccardo
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Policlin Gemelli IRCSS, Dipartimento Sci Salute Donna & Bambino & Sanita, Rome, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Ballatore, Zelmira
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Politecn Marche, Clin Oncol & Ctr Reg Genet Oncol, AOU Osped Riuniti Ancona, Ancona, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Torrisi, Rosalba
论文数: 0 引用数: 0
h-index: 0
机构:
IRCCS Humanitas Clin & Res Hosp, Dept Med Oncol, Rozzano, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Michelotti, Andrea
论文数: 0 引用数: 0
h-index: 0
机构:
Osped S Chiara, Azienda Osped Univ Pisana, UO Oncol Med 1, Pisa, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Zambelli, Alberto
论文数: 0 引用数: 0
h-index: 0
机构:
Humanitas Univ, IRCCS Res Hosp, Rozzano, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Ferro, Antonella
论文数: 0 引用数: 0
h-index: 0
机构:
Osped Santa Chiara, Med Oncol, Trento, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Generali, Daniele
论文数: 0 引用数: 0
h-index: 0
机构:
ASST Cremona, Ist Ospitalieri Cremona, UOC Multidisciplinare Patol Mammaria, Cremona, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

论文数: 引用数:
h-index:
机构:

Coltelli, Luigi
论文数: 0 引用数: 0
h-index: 0
机构:
Presidio Osped Livorno, UOC Oncol Med, Livorno, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

论文数: 引用数:
h-index:
机构:

Marchetti, Paolo
论文数: 0 引用数: 0
h-index: 0
机构:
Azienda Osped St Andrea, UOC Oncol Med, Rome, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Ballestrero, Alberto
论文数: 0 引用数: 0
h-index: 0
机构:
Osped Policlin San Martino IRCCS, Dipartimento Med Interna DIMI, Genoa, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Spazzapan, Simon
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Riferimento Oncol IRCCS, SOC Oncol Med & Prevenz Oncol, Aviano, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Frassoldati, Antonio
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Ferrara Arcispedale St Anna, Azienda Osped, UOC Oncol Clin, Ferrara, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Sarobba, Maria Giuseppina
论文数: 0 引用数: 0
h-index: 0
机构:
ASL Nuoro, Presidio Osped S Francesco, UOC Oncol, Nuoro, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Grasso, Donatella
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Farma SpA, Oncol, Origgio, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy

Zamagni, Claudio
论文数: 0 引用数: 0
h-index: 0
机构:
IRCCS Azienda Osped Univ Bologna, Addarii Med Oncol Unit, Bologna, Italy IRCCS, Fdn Pascale, Ist Nazl Tumori, Breast Oncol, Naples, Italy